ClinicalTrials.gg
RecruitingNCT06344598Updated Apr 3, 2024

Identification and Assessment of Risk Factors for the Development of Osteoporosis in Adults and Children Living in the Abay Region of the Republic of Kazakhstan Using the Method of Dual-energy X-ray Absorptiometry and Clinical and Epidemiological Research

An observational study in Improving the Early Diagnosis of Osteoporosis in Adults and Children Living in the Abay Region of Kazakhstan, sponsored by Semey State Medical University. Recruiting at 1 site in Kazakhstan. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-04-03.

Sponsored by Semey State Medical University · Observational

From the registry’s dates

  • Primary completion was expected by Nov 2025, 11 months ago, but the record still lists the study as recruiting.
  • Started Sep 2023; still recruiting 3 years 2 months later.
Study type
Observational
Model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
1,000
Ages
18 Years to 65 Years
Sex
All
01

Study summary

A survey of people to identify risk factors for osteoporosis, which include age, gender, lifestyle, diet, physical activity, the presence or absence of somatic pathology. Diagnosis of osteoporosis by dual-energy X-ray absorptiometry. Conducting a correlation analysis of the relationship of the data obtained.

Read the detailed description

Successful diagnosis of osteoporosis is possible with the complex use of clinical, laboratory and radiological methods. In the complex of diagnostic methods, a special place has given to dual-energy X-ray absorptiometry, which is the "gold standard". The research area contains the following tasks:

Risk factors for the development of osteoporosis will be identified and quantified in the formed study groups of adults; to determine the diagnostic value of the risk factors for the development of osteoporosis obtained during the examination.

to assess the state of BMD in adults using X-ray absorptiometry (DXA) To carry out a correlation analysis of the relationship between the obtained data in adults of the Abay region of of the Republic of Kazakhstan

02

Conditions studied

  • Improving the Early Diagnosis of Osteoporosis in Adults and Children Living in the Abay Region of Kazakhstan

Browse trials for

Keywords

  • osteoporosis, dual-energy X-ray absorptiometry, bone mineral density, risk factors
03

In context

Osteoporosis

1,601 studies on the registry are indexed under Osteoporosis; 209 are open to participants now.

This study's planned enrollment of 1,000 is above the median of 160 across 455 observational studies indexed under Osteoporosis.

Browse Osteoporosis studies →

Lead sponsor

Semey State Medical University is the lead sponsor of 3 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Residents of the Abay region of the Republic of Kazakhstan

Eligibility criteria

Inclusion Criteria: adults and children without a history of pathological fractures and congenital pathology of the musculoskeletal system.

-

Exclusion Criteria: adults and children with congenital pathology of the musculoskeletal system

-

05

Study design

Observational model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
1,000 participants (estimated)
Patient registry
No

Groups and cohorts

  • Persons with normal BMD
  • Persons with low BMD
06

What researchers measure

Primary outcomes

  1. Risk factors for the development of osteoporosis will be identified and quantified in the formed study groups of adults

    Time frame: By the end of Dec 2025

  2. to determine the diagnostic value of the risk factors for the development of osteoporosis obtained during the examination

    Time frame: By the end of Dec 2025

  3. to assess the state of BMD in adults using X-ray absorptiometry (DXA)

    Time frame: By the end of Dec 2025

  4. To carry out a correlation analysis of the relationship between the obtained data in adults of the Abay region of of the Republic of Kazakhstan

    Time frame: By the end of Dec 2025

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 3, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06344598
Lead sponsor
Semey State Medical University
Collaborators
Ministry of Science and Higher Education of the Republic of Kazakhstan
Responsible party
Sponsor
First posted
Apr 3, 2024
Start date
Sep 1, 2023
Primary completion
Nov 15, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Apr 3, 2024

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion